Thursday, June 26, 2008: Short Courses
An additional fee is required to attend all short courses.
8:00 am - 5:00 pm
Short Course #4: Critical Updates in Pharmaceutical Patent Law: What Every Biotech Scientist Should Know
PLEASE NOTE: Short Course #4: Critical Updates in Pharmaceutical Patent Law: What Every Biotech Scientist Should Know has been CANCELLED
All pre-registered attendees for Short Course #4 will receive information from AAPS regarding registration refunds.
Recently, practitioners have witnessed a tremendous shift in the way patents are viewed by both the Courts and the United States Patent Office, especially those patents relevant to the biopharmaceutical community. For example, the Supreme Court has very recently made it easier to invalidate patents on the grounds of "obviousness." Another Supreme Court decision has made significant changes in how licenses between biotech companies are made and valued, and yet another on the remedies available for infringement. At the same time, the courts' interpretation on how to protect patents as research tools for discovery and development continues to evolve. This short course will introduce patent basics and examine these recent lines of cases, legislative proposals to reform the Patent Code, rule changes made at the United States Patent and Trademark Office, and will then discuss the cumulative affect on the biopharmaceutical industry. The short course instructors are from academia and industry and represent an extensive and diverse set of experiences on these critically important topics.
Moderator
Eyal H. Barash, J.D., M.S.
Aptuit
The Rapid Evolution of Inherent Anticipation: Landmines for Pharmaceutical Patents
Lawrence Sung, Ph.D.
Nixon Peabody, LLP
Changing Tides for Extending Pharmaceutical Patent Protection: The Increasing Reach of Obviousness
Catherine Polizzi, Ph.D., J.D.
Morrison & Foerster
Future Challenges in Obtaining Pharmaceutical Patents: A Holistic Analysis Part I
Sri Melethil, Ph.D., J.D.
University of Findlay
The Scope of Research Tool Patents in the Pharmaceutical Sciences: Are They Enforceable?
Cynthia L. Beverage, J.D., LL.M.
Morrison & Foerster
Future Challenges in Obtaining Pharmaceutical Patents: A Holistic Analysis Part II
Eyal H. Barash, J.D., M.S.
Aptuit
A Pharmaceutical Scientist's Guide to the Galaxy of Patent Litigation-Evolving Roles and Expectations
Arie Michelsohn, J.D., Ph.D.
Finnegan Henderson